Colorectal Cancer Patients With African Ancestry Had Fewer Clinically Actionable Alterations Than White Patients
ORLANDO, Fla. – Genomic profiling of patients who were treated for colorectal cancer at a major U.S. cancer center...
Search/Filter
Loading...
Lung Cancer Incidence Rates Varied Significantly Among Florida’s Black and Hispanic Ethnic Subgroups
Disaggregating statistics revealed key differences in ethnic populations ORLANDO, Fla. – An analysis of lung cancer incidence rates showed...
Single-agent Pembrolizumab May Benefit Patients with Rare Type of Skin Cancer
ORLANDO, Fla. – Monotherapy with pembrolizumab (Keytruda) led to clinical responses in 89% of patients with unresectable metastatic desmoplastic...
A Liquid Biopsy-based Multicancer Early Detection Test May Detect Early-stage Disease and Low DNA-shedding Cancers
The multicancer early detection platform was developed based on methylation of cell-free DNA ORLANDO, Fla. – A liquid biopsy-based...
Adjuvant Treatment With Atezolizumab and Bevacizumab May Delay Recurrence After Surgical Resection in Patients With Liver Cancer
ORLANDO, Fla. – Adjuvant therapy with atezolizumab (Tecentriq) and bevacizumab (Avastin) increased recurrence-free survival of patients with hepatocellular carcinoma...
Adding a Personalized mRNA Cancer Vaccine to Immunotherapy May Prolong Recurrence-free Survival in Patients With High-risk Melanoma
Clinical benefit was independent of patients’ tumor mutational burden ORLANDO, Fla. – mRNA-4157/V940, a personalized mRNA-based cancer vaccine,...
First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers
ORLANDO, Fla. – The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated...
Durvalumab-based Treatment Before and After Surgery Improved Outcomes for Patients With Resectable Non-small Cell Lung Cancer
Patients treated with the durvalumab-based regimen before and after surgery in the AEGEAN trial had a 32% reduction in...
American Association for Cancer Research Recognizes 2022-2023 Research Grantees
PHILADELPHIA — The American Association for Cancer Research (AACR) is proud to announce its newest class of grant recipients. Since 1993,...
AACR Announces Recipients of its 2023 Scientific Achievement Awards, Lectureships, and Prizes
Awardees to be recognized at the AACR Annual Meeting 2023 in Orlando PHILADELPHIA – The American Association for Cancer...